"We have spent years building the infrastructure required to put the power of choice back into the hands of the individual, and we are committed to ensuring providers can always make the best clinical decision for their patients with an array of safe options to help find care that fits their lifestyle, Andrew Dudum, co-founder and CEO of Hims & Hers, said in a statement "Were excited to find ways to continue bringing branded treatments to the platform across specialties
Reports have described possible increases in circulating growth hormone and IGF-1 over time, alongside observations of tissue-level changes such as dermal thickness and cellular proliferation
By starting with a low dose, we help minimize side effects and let your body adapt
Success with semaglutide GLP-1 depends on factors like medication adherence, commitment to a healthy lifestyle, and your unique metabolic health
The emergence of dual agonists like Tirzepatide shows how combining pathways can significantly enhance outcomes, raising the bar for both efficacy and patient results